is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to [Limited Offer] GIP / GLP-1
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://www.luxora.shop/cdn/shop/files/Gemini_Generated_Image_p756i4p756i4p756.png?v=1775532162&width=480)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://cdn1.npcdn.net/images/1771916763bf18cd9900f5f08f23f6f0d8fb5cbe45.webp?md5id=43d5b8fc1b0674e7cfd04c36d6bb6442&new_width=1000&new_height=1000&size=max&w=-62170008925&from=png&type=10)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://v.cdn.ww.com/media/system/cms/us/GLP_1_comparison.jpg)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://i.abcnewsfe.com/a/ed9f4811-7c11-41e9-85b2-efa2fc8004b7/weight-loss-drugs-mounjaro-gty-bh-251130_1764523075114_hpMain_16x9.jpg?w=992)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://media.post.rvohealth.io/wp-content/uploads/2026/06/GLP1_Roundup-header-1296x728-2.jpg)






















